ClinicalTrials.govpublic full text
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
pancreatic cancer, antibiotics, resectable, microbiome, pembrolizumab, chemotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1008490
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.